PDL BioPharma , Inc. ( PDLI ) declares $0.15/share quarterly dividend , in line with previous. Forward yield 7.28% Payable Dec. 12; for shareholders of record Dec. 5; ex-div Dec. 3. 1 comment!
PDL BioPharma ( PDLI -1.1% ) is out with revenue guidance for Q4. The company sees sales of ~$109M (+27% Y/Y). ( PR ) Consensus is $119.57M. 2 comments!
NEW YORK, Dec 10 (Reuters) - PDL BioPharma Inc : * Shares were up 1.5 percent afer the bell following guidance
PDL BioPharma , Inc. ( PDLI ) Piper Jaffray 2013 Healthcare Conference Call December 3, 2013 3:00 ..... a pleasure to introduce the next presenting company and that is PDL BioPharma . I would argue that PDL is probably one of the more interesting business
PDL BioPharma ( PDLI -13.3% ) is having a tough session, down double-digits on nearly double its 10-day average volume. Perhaps helping to
UNIS +17% . INS +14% . ICLD +13% . IDSA +12% . TSLA +12% . Top 10 Losers: KKD -20% . ECTE -17% . YRCW -15% . CAMT -14% . SYUT -13% . LDOS -12% . AZC -12% . PDLI -12% . MBIS -11% . BSPM -10% . Post your comment!
By Ruerd Heeg : PDL BioPharma ( PDLI ) is a small cap with a market capitalization of about $1.35 billion. Its stock has gone up from $4 in 2011 to almost $10
PDL BioPharma , Inc. ( PDLI ) Jeffries 2013 Global Healthcare Conference Call November 21, 2013 ..... President and CEO and Peter Garcia, Chief Financial Officer of PDL BioPharma . John? John McLaughlin Thanks very much. Good morning, welcome
PDL BioPharma Inc. ( PDLI ) Credit Suisse Healthcare Conference November 13, 2013 12:30 PM ..... analyst here at Credit Suisse. It’s my pleasure to be introducing PDL Biopharma , a very exciting story. I think the highest dividend paying biotechnology
PDL BioPharma , Inc. ( PDLI ) Q3 2013 Results Earnings Call November 6, 2013 4:30 PM ET ..... and Company Presentation Operator Good afternoon. And welcome to PDL BioPharma Third Quarter 2013 Earnings Conference Call. Today’s call is being